MetaVia, Inc. (MTVA)
1.84
+0.02
(+1.10%)
USD |
NASDAQ |
Sep 03, 16:00
1.78
-0.06
(-3.26%)
After-Hours: 20:00
MetaVia Enterprise Value : -0.3577M for Sept. 3, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 03, 2026 | -0.3577M |
| September 02, 2026 | -0.4892M |
| September 01, 2026 | -1.147M |
| August 31, 2026 | -1.147M |
| August 28, 2026 | -1.278M |
| August 27, 2026 | -1.541M |
| August 26, 2026 | -1.410M |
| August 25, 2026 | -1.673M |
| August 24, 2026 | -2.396M |
| August 21, 2026 | -2.856M |
| August 20, 2026 | -2.988M |
| August 19, 2026 | -2.791M |
| August 18, 2026 | -2.659M |
| August 17, 2026 | -2.725M |
| August 14, 2026 | -2.659M |
| August 13, 2026 | -2.856M |
| August 12, 2026 | -2.791M |
| August 11, 2026 | -3.120M |
| August 10, 2026 | -3.054M |
| August 07, 2026 | -2.659M |
| August 06, 2026 | -2.922M |
| August 05, 2026 | -2.659M |
| August 04, 2026 | -2.856M |
| August 03, 2026 | -2.725M |
| July 31, 2026 | -3.120M |
| Date | Value |
|---|---|
| July 30, 2026 | -2.988M |
| July 29, 2026 | -2.988M |
| July 28, 2026 | -3.054M |
| July 27, 2026 | -2.922M |
| July 24, 2026 | -2.725M |
| July 23, 2026 | -2.528M |
| July 22, 2026 | -2.067M |
| July 21, 2026 | -2.067M |
| July 20, 2026 | -1.410M |
| July 17, 2026 | -1.213M |
| July 16, 2026 | -0.6207M |
| July 15, 2026 | -0.292M |
| July 14, 2026 | 0.2341M |
| July 13, 2026 | 0.6286M |
| July 10, 2026 | -0.7523M |
| July 09, 2026 | -1.081M |
| July 08, 2026 | -2.199M |
| July 07, 2026 | -2.067M |
| July 06, 2026 | -2.528M |
| July 02, 2026 | -2.725M |
| July 01, 2026 | -2.922M |
| June 30, 2026 | -3.054M |
| June 29, 2026 | -5.842M |
| June 26, 2026 | -6.152M |
| June 25, 2026 | -5.636M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ionis Pharmaceuticals, Inc. | 9.763B |
| aTyr Pharma, Inc. | 3.074M |
| ACADIA Pharmaceuticals, Inc. | 3.913B |
| Alnylam Pharmaceuticals, Inc. | 35.05B |
| Anika Therapeutics, Inc. | 267.88M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.316M |
| Total Expenses (Quarterly) | 5.316M |
| EPS Diluted (Quarterly) | -0.8962 |
| Earnings Yield | -219.6% |
| Normalized Earnings Yield | -220.08 |